SEC Form 4 · accession 0001209191-16-121465
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuval Cohen
Officer — Chief Executive Officer · Director
Period of report
May 18, 2016
Accepted (ET)
May 19, 2016 · 7:41 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2016 | P | 2,125 | $2.40 | A | 9,990 | D |
Table II — derivative securities
No Table II lines on this filing.